1 Cooper, C, Westlake, S, Harvey, N, et al. (2006) Review: developmental origins of osteoporotic fracture. Osteoporos Int 17, 337–347.
2 Dennison, E, Cole, Z & Cooper, C (2005) Diagnosis and epidemiology of osteoporosis. Curr Opin Rheumatol 17, 456–461.
3 Zhang, Y, Chen, WF, Lai, WP, et al. (2008) Soy isoflavones and their bone protective effects. Inflammopharmacology 16, 213–215.
4 Huot, L, Couris, CM, Tainturier, V, et al. (2008) Trends in HRT and anti-osteoporosis medication prescribing in a European population after the WHI study. Osteoporos Int 19, 1047–1054.
5 Palacios, S (2008) Advances in hormone replacement therapy: making the menopause manageable. BMC Womens Health 8, 22.
6 Hertrampf, T, Gruca, MJ, Seibel, J, et al. (2007) The bone-protective effect of the phytoestrogen genistein is mediated via ER α-dependent mechanisms and strongly enhanced by physical activity. Bone 40, 1529–1535.
7 Szkudelska, K & Nogowski, L (2007) Genistein-α dietary compound inducing hormonal and metabolic changes. J Steroid Biochem Mol Biol 105, 37–45.
8 Sato, M, Tanaka, H, Yamaguchi, R, et al. (2004) Synergistic effects of mupirocin and an isoflavanone isolated from Erythrina variegata on growth and recovery of methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 24, 241–246.
9 Cox, PA (1993) Saving the ethnopharmacological heritage of Samoa. J Ethnopharmacol 38, 181–188.
10 Sato, M, Tanaka, H, Fujiwara, S, et al. (2003) Antibacterial property of isoflavonoids isolated from Erythrina variegata against cariogenic oral bacteria. Phytomedicine 10, 427–433.
11 Zhang, Y, Li, XL, Yao, XS, et al. (2008) Osteogenic activities of genistein derivatives were influenced by the presence of prenyl group at ring A. Arch Pharm Res 31, 1534–1539.
12 Li, XL, Wang, NL, Wong, MS, et al. (2006) Four new isoflavonoids from the stem bark of Erythrina variegata. Chem Pharm Bull 54, 570–573.
13 Zhang, Y, Li, XL, Lai, WP, et al. (2007) Anti-osteoporotic effect of Erythrina variegata L. in ovariectomized rats. J Ethnopharmacol 109, 165–169.
14 Zhang, Y, Li, Q, Wan, Hoi-Ying, et al. (2009) Genistein and a soy extract differentially affect three-dimensional bone parameters and bone-specific gene expression in ovariectomized mice. J Nutr 139, 2230–2236.
15 Zhang, Y, Lai, WP, Leung, PC, et al. (2007) Short- to mid-term effects of ovariectomy on bone turnover, bone mass and bone strength in rats. Biol Pharm Bull 30, 898–903.
16 Zhang, Y, Lai, WP, Leung, PC, et al. (2008) Improvement of Ca balance by Fructus Ligustri Lucidi extract in aged female rats. Osteoporos Int 19, 235–242.
17 Zhang, Y, Dong, XL, Leung, PC, et al. (2009) Differential mRNA expression profiles in proximal tibia of aged rats in response to ovariectomy and low-Ca diet. Bone 44, 46–52.
18 Li, XL
19 Hie, M, Shimono, M, Fujii, K, et al. (2007) Increased cathepsin K and tartrate-resistant acid phosphatase expression in bone of streptozotocin-induced diabetic rats. Bone 41, 1045–1050.
20 Pennypacker, B, Shea, M, Liu, Q, et al. (2009) Bone density, strength, and formation in adult cathepsin K ( − / − ) mice. Bone 44, 199–207.
21 Odvina, CV, Poindexter, JR, Peterson, RD, et al. (2008) Intestinal hyperabsorption of calcium and low bone turnover in hypercalciuric postmenopausal osteoporosis. Urol Res 36, 233–239.
22 Sahota, O, Mundey, MK, San, P, et al. (2004) The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone 35, 312–319.
23 Leibbrandt, A & Penninger, JM (2008) RANK/RANKL: regulators of immune responses and bone physiology. Ann N Y Acad Sci 1143, 123–150.
24 Hayman, AR (2008) Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomy. Autoimmunity 41, 218–223.